Found: 3
Select item for more details and to access through your institution.
Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 2, p. 221, doi. 10.1093/cid/cit226
- By:
- Publication type:
- Article
Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034372
- By:
- Publication type:
- Article
Compensatory substitutions in the HCV NS3/4A protease cleavage sites are not observed in patients treated unsuccessfully with telaprevir combination treatment.
- Published in:
- Virology Journal, 2012, v. 9, n. 1, p. 147, doi. 10.1186/1743-422X-9-147
- By:
- Publication type:
- Article